GW Pharmaceuticals Plc (GWPH): Stock Offering News

GWPH – Prices 28.8 mln shares of common stock at $115.00 per AD.


Key Facts Surrounding This News Item


  • GWPH had a POWR Rating of B (Buy) coming into today.
  • GWPH was -5.15% below its 10-Day Moving Average coming into today.
  • GWPH was -2.35% below its 20-Day Moving Average coming into today.
  • GWPH was 2.84% above its 50-Day Moving Average coming into today.
  • GWPH was 5.22% above its 100-Day Moving Average coming into today.
  • GWPH was 4.54% above its 200-Day Moving Average coming into today.
  • GWPH had returned +3.80% year-to-date leading up to today’s news, versus a +19.44% return from the benchmark S&P 500 during the same period.

More Info About GW Pharmaceuticals Plc (GWPH)


GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company was founded in 1998 and is based in Cambridge, the United Kingdom. View our full GWPH ticker page with ratings, news, and more.

GWPH at a Glance

GWPH Current POWR Rating™
Overall POWR Rating™
GWPH Current Price $122.89 0.47%
More GWPH Ratings, Data, and News

GWPH Price Reaction

The day of this event (Dec. 7, 2017)
GWPH Closing Price$124.97 7.73%
GWPH Volume1,240,700
271.83% from avg
Leading up to this event
GWPH 1-mo return2.37%
After this event
GWPH 1-day return5.99%
GWPH 3-day return5.17%

GWPH Price Chart



More GW Pharmaceuticals Plc (GWPH) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GWPH News
Page generated in 1.6267 seconds.